Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Biogen Inc.
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Biotech
Market Cap: $17.41B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.47 | 1.32%
Avg Daily Range (30 D): $2.26 | 1.81%
Avg Daily Range (90 D): $2.06 | 1.51%
Institutional Daily Volume
Avg Daily Volume: 2.09M
Avg Daily Volume (30 D): 1.27M
Avg Daily Volume (90 D): 1.23M
Trade Size
Avg Trade Size (Sh.): 109
Avg Trade Size (Sh.) (30 D): 40
Avg Trade Size (Sh.) (90 D): 40
Institutional Trades
Total Inst.Trades: 43,954
Avg Inst. Trade: $5.96M
Avg Inst. Trade (30 D): $14.88M
Avg Inst. Trade (90 D): $13.55M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 8
Market Closing Trades
Avg Closing Trade: $27.71M
Avg Closing Trade (30 D): $42.76M
Avg Closing Trade (90 D): $41.95M
Avg Closing Volume: 132.02K
       
News
Apr 15, 2025 @ 11:00 PM
Leqembi®∇ (lecanemab) is the First Medici...
Source: N/A
Apr 10, 2025 @ 5:58 PM
Specialists Set Sights on CLE Pipeline as Unmet Ne...
Source: Spherix Global Insights
Apr 10, 2025 @ 9:59 AM
Biopharmaceuticals Global Overview Report 2025: Gl...
Source: Researchandmarkets.Com
Mar 27, 2025 @ 1:15 PM
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly ...
Source: Adam Spatacco
Mar 21, 2025 @ 4:31 PM
Pharmaceutical Firms Say UK Investment Is 'Unlikel...
Source: Vandana Singh
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $11.1 $2.67 $4.01
Diluted EPS $11.06 $2.66 $4
Revenue $ 9.61B $ 2.47B $ 2.46B
Gross Profit $ 7.26B $ 1.83B $ 1.92B
Net Income / Loss $ 1.61B $ 388.5M $ 583.6M
Operating Income / Loss $ 1.91B $ 451M $ 698.7M
Cost of Revenue $ 2.35B $ 638.7M $ 546M
Net Cash Flow $ -588.7M $ -209.7M $ 834.5M
PE Ratio 10.75    
Splits
Jan 18, 2001:   1:3